CD8A and cancer: Using Spearman’s correlation and Wilcoxon signed-rank tests, the risk score was found to be related to several widely studied immune cells (such as B cells, CD8+ T cells, and cancer-associated fibroblasts) on different platforms (Figures 7B,C).